Cargando…

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study

INTRODUCTION: There is a lack of data on potential gender differences in the use of interventions to prevent and treat cardiovascular disease (CVD) in HIV-positive individuals. We investigated whether such differences exist in the D:A:D study. MATERIALS AND METHODS: Follow-up was from 01/02/99 until...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatleberg, Camilla Ingrid, Ryom, Lene, El-Sadr, Wafaa, Mocroft, Amanda, Reiss, Peter, de Wit, Stephan, Dabis, Francois, Pradier, Christian, d'Arminio Monforte, Antonella, Rickenbach, Martin, Law, Matthew, Lundgren, Jens, Sabin, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Oral Presentation – Abstract O324
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224835/ https://www.ncbi.nlm.nih.gov/pubmed/25394025 http://dx.doi.org/10.7448/IAS.17.4.19516

Ejemplares similares

Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study
por: Smith, Colette, et al.
Publicado: (2014)

Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study
por: Hatleberg, Camilla I, et al.
Publicado: (2018)

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study()
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2019)

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
por: Boyd, Mark A., et al.
Publicado: (2017)

Cell-Free DNA Tissue Damage Mapping in Transplant Patients Infected with COVID-19
por: Andargie, T.E., et al.
Publicado: (2021)

Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals: Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study
por: Worm, Signe W., et al.
Publicado: (2009)

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration
por: Sabin, Caroline A., et al.
Publicado: (2016)

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
por: Boettiger, David C, et al.
Publicado: (2021)

Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
por: Petoumenos, Kathy, et al.
Publicado: (2012)

Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
por: Kovari, Helen, et al.
Publicado: (2016)

A clinically useful risk-score for chronic kidney disease in HIV infection
por: Mocroft, Amanda, et al.
Publicado: (2014)

Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study
por: Worm, Signe W, et al.
Publicado: (2013)

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study
por: Kamara, David A, et al.
Publicado: (2014)

Cardiovascular risk evaluation of HIV-positive patients in a case-control study: comparison of the D:A:D and Framingham equations
por: Markowicz, Samuel, et al.
Publicado: (2014)

A comparison of estimated glomerular filtration rates using Cockcroft−Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection
por: Mocroft, A, et al.
Publicado: (2014)

Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
por: Mocroft, Amanda, et al.
Publicado: (2015)

Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA
por: Shepherd, Leah, et al.
Publicado: (2014)

From guidelines to action: implementation opportunities and realities
por: El-Sadr, Wafaa
Publicado: (2014)

CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in Italy
por: Madeddu, Giordano, et al.
Publicado: (2014)

Regional differences in self-reported HIV care and management in the EuroSIDA study
por: Grønborg Laut, Kamilla, et al.
Publicado: (2014)

A pilot study to determine the prevalence of HIV in persons presenting for care with selected conditions: preliminary results from the HIV in Europe study
por: Sönnerborg, A, et al.
Publicado: (2010)

Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA
por: Ryom, L, et al.
Publicado: (2010)

When to start: not so fast
por: Lundgren, J
Publicado: (2012)

Review of life expectancy in people with HIV in settings with optimal ART access: what we know and what we don't
por: Sabin, C
Publicado: (2012)

HIV, co-morbidity and ageing
por: Reiss, P
Publicado: (2012)

Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study
por: May, M, et al.
Publicado: (2012)

Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America
por: Efsen, Anne Marie, et al.
Publicado: (2014)

Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
por: Lodi, S, et al.
Publicado: (2010)

Models of care and delivery
por: Lundgren, Jens
Publicado: (2014)

Manifestations musculosquelettiques du SRAS-CoV-2 dans une population pédiatrique – expérience d’une unité de rhumatologie pédiatrique
por: Silva, A. Gaspar, et al.
Publicado: (2022)

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study
por: Viard, JP, et al.
Publicado: (2010)

Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV
por: Greenberg, Lauren, et al.
Publicado: (2023)

Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature
por: Tincati, Camilla, et al.
Publicado: (2018)

Rate of viral load failure over time in people on ART in the UK Collaborative HIV Cohort (CHIC) study
por: O'Connor, Jemma, et al.
Publicado: (2014)

Does pregnancy increase the risk of ART-induced hepatotoxicity among HIV-positive women?
por: Huntington, Susie, et al.
Publicado: (2014)

Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?
por: Tincati, Camilla, et al.
Publicado: (2020)

Determinants of IL-6 levels during HIV infection
por: Borges, Álvaro H, et al.
Publicado: (2014)

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe
por: Mocroft, Amanda, et al.
Publicado: (2014)

Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting
por: Greenberg, Lauren, et al.
Publicado: (2022)

Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection
por: Augello, Matteo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5h8sb8l969p3rir8j43463p8vc